Basic Information
RNALocate ID: RLID:11000728
RNA Symbol: hsa-miR-19b-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-19b-3p
RNA ID: miRBase:MIMAT0000074
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23663360
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001283 Cytoplasm Nasopharyngeal carcinoma cells 20498841
RLID:01001284 Cytoplasm Colon cancer cells 20864815
RLID:01001285 Cytoplasm Cell line (HeLa) 21695135
RLID:01001286 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001287 Mitochondrion Myotube 27396686
RLID:01001288 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01001289 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01001290 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001291 Nucleolus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001292 Nucleus GC cell line (MGC-803) 29872807
RLID:01001293 Nucleus Nasopharyngeal carcinoma cells 20498841
RLID:11000724 Exosome Glioblastoma cells 19011622
RLID:11000725 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11000726 Exosome Renal cancer cells 21670082
RLID:11000727 Exosome Brain tissue 23382797
RLID:11000729 Exosome Human mast cell line (HMC-1) 24009880
RLID:11000730 Exosome Human esophageal cancer cell line (EC9706) 25184951
RLID:11000731 Exosome Colon cancer cell line (LIM1863) 25330373
RLID:11000732 Extracellular Vesicle Liposarcoma cell lines (Lipo246|Lipo863|LPS141)|Preadipocytes 28588009
RLID:11000733 Microvesicle Glioblastoma cells 19011622
RLID:11000734 Microvesicle Seminal plasma 23539611
RLID:11000735 Microvesicle Follicular fluid 23666971
RLID:11000736 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000011 Exosome B lymphoblastoid cells|Breast milk|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue
RLID-D:11000273 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-19b-3p Diffuse large b cell lymphoma MNDR-E-MI-25628
MNDR hsa-miR-19b-3p Mantle cell lymphoma MNDR-E-MI-25629
MNDR hsa-miR-19b-3p Splenic marginal zone lymphoma MNDR-E-MI-25630
MNDR hsa-miR-19b-3p Multiple sclerosis chronic progressive MNDR-E-MI-25631
MNDR hsa-miR-19b-3p Oral squamous cell carcinoma MNDR-E-MI-25632
MNDR hsa-miR-19b-3p Large cell neuroendocrine cancer MNDR-E-MI-25633
MNDR hsa-miR-19b-3p Medulloblastoma MNDR-E-MI-25634
MNDR hsa-miR-19b-3p Uterine corpus endometrial carcinoma MNDR-E-MI-25635
MNDR hsa-miR-19b-3p Lymphoma MNDR-E-MI-25636
MNDR hsa-miR-19b-3p Lymphoma non-hodgkin MNDR-E-MI-25637
MNDR hsa-miR-19b-3p Estrogen-receptor negative breast cancer MNDR-E-MI-25638
MNDR hsa-miR-19b-3p Progesterone-receptor negative breast cancer MNDR-E-MI-25639
MNDR hsa-miR-19b-3p Her2-receptor positive breast cancer MNDR-E-MI-25640
MNDR hsa-miR-19b-3p Niemann-pick disease type c MNDR-E-MI-25641
MNDR hsa-miR-19b-3p Prostate cancer MNDR-E-MI-25642
MNDR hsa-miR-19b-3p Gastric cancer MNDR-E-MI-25643
MNDR hsa-miR-19b-3p Gastric lymphoma MNDR-E-MI-25644
MNDR hsa-miR-19b-3p Alzheimer disease MNDR-E-MI-25645
MNDR hsa-miR-19b-3p Encephalitis japanese MNDR-E-MI-25646
MNDR hsa-miR-19b-3p Intracranial aneurysm MNDR-E-MI-25647
MNDR hsa-miR-19b-3p Bladder cancer MNDR-E-MI-25648
MNDR hsa-miR-19b-3p Sarcoma MNDR-E-MI-25649
MNDR hsa-miR-19b-3p Dysautonomia familial MNDR-E-MI-25650
MNDR hsa-miR-19b-3p Head and neck cancer MNDR-E-MI-25651
MNDR hsa-miR-19b-3p Huntington disease MNDR-E-MI-25652
MNDR hsa-miR-19b-3p Chorea MNDR-E-MI-25653
MNDR hsa-miR-19b-3p Cardiovascular disease MNDR-E-MI-25654
MNDR hsa-miR-19b-3p Carotid stenosis MNDR-E-MI-25655
MNDR hsa-miR-19b-3p Moyamoya disease MNDR-E-MI-25656
MNDR hsa-miR-19b-3p Lung cancer MNDR-E-MI-25657
MNDR hsa-miR-19b-3p Fragile x syndrome MNDR-E-MI-25658
MNDR hsa-miR-19b-3p Parkinson disease MNDR-E-MI-25659
MNDR hsa-miR-19b-3p Machado-joseph disease MNDR-E-MI-25660
MNDR hsa-miR-19b-3p Niemann-pick disease MNDR-E-MI-25661
MNDR hsa-miR-19b-3p Basal-like breast cancer MNDR-E-MI-25662
MNDR hsa-miR-19b-3p Squamous cell carcinoma MNDR-E-MI-25663
MNDR hsa-miR-19b-3p Thyroid cancer MNDR-E-MI-25664
MNDR hsa-miR-19b-3p Pancreatic cancer MNDR-E-MI-25665
MNDR hsa-miR-19b-3p Malignant melanoma MNDR-E-MI-25666
MNDR hsa-miR-19b-3p Atherosclerosis MNDR-E-MI-25667
MNDR hsa-miR-19b-3p Rectum adenocarcinoma MNDR-E-MI-25668
MNDR hsa-miR-19b-3p Nephroblastoma MNDR-E-MI-25669
MNDR hsa-miR-19b-3p Colon cancer MNDR-E-MI-25670
MNDR hsa-miR-19b-3p Ischemic attack transient MNDR-E-MI-25671
MNDR hsa-miR-19b-3p Colon adenocarcinoma MNDR-E-MI-25672
MNDR hsa-miR-19b-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-25673
MNDR hsa-miR-19b-3p Familial ovarian cancer MNDR-E-MI-25674
MNDR hsa-miR-19b-3p Basal cell carcinoma MNDR-E-MI-25675
MNDR hsa-miR-19b-3p Prostate adenocarcinoma MNDR-E-MI-25676
MNDR hsa-miR-19b-3p Kidney cancer MNDR-E-MI-25677
MNDR hsa-miR-19b-3p Thyroid adenomas MNDR-E-MI-25678
MNDR hsa-miR-19b-3p Carcinoma ductal breast MNDR-E-MI-25679
MNDR hsa-miR-19b-3p Glioblastoma MNDR-E-MI-25680
MNDR hsa-miR-19b-3p Astrocytoma MNDR-E-MI-25681
MNDR hsa-miR-19b-3p Glioma MNDR-E-MI-25682
MNDR hsa-miR-19b-3p Chronic obstructive pulmonary disease MNDR-E-MI-25683
MNDR hsa-miR-19b-3p Central nervous system lymphoma MNDR-E-MI-25684
MNDR hsa-miR-19b-3p Amyotrophic lateral sclerosis MNDR-E-MI-25685
MNDR hsa-miR-19b-3p Osteosarcoma MNDR-E-MI-25686
MNDR hsa-miR-19b-3p Liposarcoma MNDR-E-MI-25687
MNDR hsa-miR-19b-3p Coronary artery disease MNDR-E-MI-25688
MNDR hsa-miR-19b-3p Meningioma MNDR-E-MI-25689
MNDR hsa-miR-19b-3p Liver cancer MNDR-E-MI-25690
MNDR hsa-miR-19b-3p Cervical adenocarcinoma MNDR-E-MI-25691
MNDR hsa-miR-19b-3p Gastric adenocarcinoma MNDR-E-MI-25692
MNDR hsa-miR-19b-3p Cervical squamous cell carcinoma MNDR-E-MI-25693
MNDR hsa-miR-19b-3p Lung squamous cell carcinoma MNDR-E-MI-25694
MNDR hsa-miR-19b-3p Carcinoma lung non-small-cell MNDR-E-MI-25695
MNDR hsa-miR-19b-3p Lung adenocarcinoma MNDR-E-MI-25696
MNDR hsa-miR-19b-3p Thyroid carcinoma MNDR-E-MI-25697
MNDR hsa-miR-19b-3p Bladder urothelial carcinoma MNDR-E-MI-25698
MNDR hsa-miR-19b-3p Cervical cancer MNDR-E-MI-25699
MNDR hsa-miR-19b-3p Myasthenia gravis autoimmune experimental MNDR-E-MI-25700
MNDR hsa-miR-19b-3p Carcinoma renal cell MNDR-E-MI-25701
MNDR hsa-miR-19b-3p Kidney renal papillary cell carcinoma MNDR-E-MI-25702
MNDR hsa-miR-19b-3p Renal clear cell carcinoma MNDR-E-MI-25703
MNDR hsa-miR-19b-3p Biliary tract cancer MNDR-E-MI-25704
MNDR hsa-miR-19b-3p Cholangiocarcinoma MNDR-E-MI-25705
MNDR hsa-miR-19b-3p Esophageal cancer MNDR-E-MI-25706
MNDR hsa-miR-19b-3p Lung small cell carcinoma MNDR-E-MI-25707
MNDR hsa-miR-19b-3p Head and neck squamous cell carcinoma MNDR-E-MI-25708
MNDR hsa-miR-19b-3p Encephalomyelitis MNDR-E-MI-25709
MNDR hsa-miR-19b-3p Breast invasive carcinoma MNDR-E-MI-25710
MNDR hsa-miR-19b-3p Hepatocellular carcinoma MNDR-E-MI-25711
MNDR hsa-miR-19b-3p Familiar ovarian carcinoma MNDR-E-MI-25712
MNDR hsa-miR-19b-3p B-cell lymphoma MNDR-E-MI-25713
MNDR hsa-miR-19b-3p Rheumatoid arthritis MNDR-E-MI-25714
MNDR hsa-miR-19b-3p T-cell leukemia MNDR-E-MI-25715
MNDR hsa-miR-19b-3p Cervical carcinoma MNDR-E-MI-25716
MNDR hsa-miR-19b-3p Retinoblastoma MNDR-E-MI-25717
MNDR hsa-miR-19b-3p Neuroblastoma MNDR-E-MI-25718
MNDR hsa-miR-19b-3p Hodgkin lymphoma MNDR-E-MI-25719
MNDR hsa-miR-19b-3p Burkitt lymphoma MNDR-E-MI-25720
MNDR hsa-miR-19b-3p Lymphosarcoma MNDR-E-MI-25721
MNDR hsa-miR-19b-3p Crohn disease MNDR-E-MI-25722
MNDR hsa-miR-19b-3p Intermediate coronary syndrome MNDR-E-MI-25723
MNDR hsa-miR-19b-3p Tonsil cancer MNDR-E-MI-25724
MNDR hsa-miR-19b-3p Acute myelogenous leukemia MNDR-E-MI-25725
MNDR hsa-miR-19b-3p Colorectal cancer MNDR-E-MI-25726
MNDR hsa-miR-19b-3p Nasopharyngeal carcinoma MNDR-E-MI-25727
MNDR hsa-miR-19b-3p Nasopharynx carcinoma MNDR-E-MI-25728
MNDR hsa-miR-19b-3p Multiple myeloma MNDR-E-MI-25729
MNDR hsa-miR-19b-3p Carcinoid tumors intestinal MNDR-E-MI-25730
MNDR hsa-miR-19b-3p Esophageal squamous cell carcinoma MNDR-E-MI-25731
MNDR hsa-miR-19b-3p Uterine cervical neoplasms MNDR-E-MI-25732
MNDR hsa-miR-19b-3p Ependymoma MNDR-E-MI-25733
MNDR hsa-miR-19b-3p Nasopharyngeal cancer MNDR-E-MI-25734
MNDR hsa-miR-19b-3p Prostatic neoplasms MNDR-E-MI-25735
MNDR hsa-miR-19b-3p Stroke lacunar MNDR-E-MI-25736
MNDR hsa-miR-19b-3p Duke A MNDR-E-MI-25737
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCB1 Homo sapiens RR00022778
TOP